Evidence map›Paper›PMID 40391100›Full record

ArticleFrontiers in public health2025

SARS-CoV-2 seroprevalence among learners in grades 1-7, their parents and teachers in KwaZulu-Natal, South Africa: a cross-sectional study.

Reshmi Dassaye, Terusha Chetty, Brodie Daniels, Trisha Ramraj, Zakir Gaffoor, Elizabeth Spooner, Ncengani Mthethwa, Duduzile Faith Nsibande, Vuyolwethu Magasana, Khanya Mohlabi and 4 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Reshmi DassayeHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Terusha ChettyHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Brodie DanielsHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Trisha RamrajHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Zakir GaffoorHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Elizabeth SpoonerHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Ncengani MthethwaHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Duduzile Faith NsibandeHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Vuyolwethu MagasanaHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Khanya MohlabiHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Isaac SinginiBiostatistics Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Nomonde GwebusheBiostatistics Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Kubashni WoeberHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Ameena GogaHIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Tygerberg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: There is limited information on SARS-CoV-2 seroprevalence among children and adolescents in LMIC school settings. We aimed to assess (1) the seroprevalence of SARS-CoV-2 antibodies, (2) prevalence of self-reported or confirmed SARS-CoV-2 prior infections and, (3) COVID-19 symptoms (including long-COVID) among a cohort of primary school learners, their parents and teachers in a semi-rural school setting approximately 3-years into the COVID-19 pandemic. Methods: Learners in grades 1-7 attending two pre-selected schools in close proximity in the Ndwedwe area, iLembe district, KwaZulu-Natal, South Africa, their parents and teachers were invited to enroll into the COVID Kids Schools Study (CoKiDSS) - a cross-sectional survey conducted between May-August 2023. All participants provided informed consent, completed a questionnaire and provided a fingerprick of blood for SARS-CoV-2 antibody testing using the COVID-19 IgG/IgM Rapid Test. Statistical methods included descriptive analysis, jackknife-estimated seroprevalence and incidence (unadjusted and sensitivity-adjusted), and logistic regression using generalized linear models. Results: A total of 645 participants (i.e., 456 learners, 147 parents and 42 teachers) were enrolled into the survey. Overall SARS-CoV-2 IgG seroprevalence was 78% unadjusted to 81% adjusted with an increasing seropositivity trend, from learners to teachers (76% unadjusted to 79% adjusted in learners, 79% unadjusted to 82% adjusted in parents and 93% unadjusted to 97% adjusted in teachers). About 2.6% of learners tested IgM seropositive. Interestingly, 17% of the participants, including 20% learners, tested negative for SARS-CoV-2 antibodies. While only 16 participants (2.5% - 2 learners, 10 parents, and four teachers) self-reported a prior confirmed SARS-CoV-2 infection. Of these 2 learners (100%), eight parents (80%) and 4 teachers (100%) reported COVID-19 like symptoms that persisted for ≥28-days. Conclusion: We reported high SARS-CoV-2 IgG seroprevalence among learners in grades 1-7, their parents and teacher approximately 3 years into the COVID-19 pandemic which may be attributed to the snowball effect of multiple waves of infection in South Africa. However, only a small proportion of participants self-reported prior COVID-19 infection. This may be due to (1) recall bias and participants' perception of low susceptibility to and severity of COVID-19, (2) limited access to SARS-CoV-2 testing, and/or (3) a high prevalence of asymptomatic infections.

Indexed as

COVID-19ParentsSARS-CoV-2School TeachersStudentsAdolescentAdultChildCross-Sectional StudiesFemaleHumansMalePrevalenceSchoolsSeroepidemiologic StudiesSouth AfricaCOVID-19learnerslong COVIDSARS-CoV-2seroprevalence

Identifiers

PMID40391100
PMCPMC12087011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.